Afua Ampadu-Yeboah, Alistair Carr, Frederick Ho, Jason Gill, Naveed Sattar, Bhautesh Dinesh Jani
{"title":"Classification and Severity Assessment of Obesity in Clinical Risk Prediction of Multimorbidity Trajectories","authors":"Afua Ampadu-Yeboah, Alistair Carr, Frederick Ho, Jason Gill, Naveed Sattar, Bhautesh Dinesh Jani","doi":"10.1111/cob.70097","DOIUrl":null,"url":null,"abstract":"<p>Obesity is a key risk factor for chronic disease and multimorbidity, yet variation in how obesity is defined may influence risk estimation in clinical practise. Waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) are better at capturing fat distribution than body mass index (BMI) and may have a role in obesity related multimorbidity prediction. To examine multimorbidity risk across obesity groups classified using BMI in combination with WHR/WHtR. A UK Biobank cohort free of comorbidity at baseline (<i>n</i> = 179 876) was followed for incident first long-term condition and multimorbidity (≥ 2 of 38 conditions) over a mean of 9.9 years. Six adiposity categories combining BMI with WHR/WHtR were analysed using Cox proportional hazards models. Subgroup analyses evaluated whether high central obesity (WHtR ≥ 0.6) provided additional risk stratification within BMI groups. Combined general with central obesity showed highest risk for the first condition (HR 1.11; 95% CI 1.087–1.138) and multimorbidity (HR 1.13; 95% CI 1.093–1.172). However, BMI-stratified subgroup analyses, central obesity provided additional risk discrimination only among individuals in the overweight category (BMI 25–29.9 kg/m<sup>2</sup>), but not among those with BMI ≥ 30 kg/m<sup>2</sup>. Waist-based measures improved risk identification in adults with overweight BMI, supporting the potential role of combined BMI-waist approaches for earlier multimorbidity prevention.</p>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":"16 4","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2026-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cob.70097","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Obesity","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cob.70097","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Obesity is a key risk factor for chronic disease and multimorbidity, yet variation in how obesity is defined may influence risk estimation in clinical practise. Waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) are better at capturing fat distribution than body mass index (BMI) and may have a role in obesity related multimorbidity prediction. To examine multimorbidity risk across obesity groups classified using BMI in combination with WHR/WHtR. A UK Biobank cohort free of comorbidity at baseline (n = 179 876) was followed for incident first long-term condition and multimorbidity (≥ 2 of 38 conditions) over a mean of 9.9 years. Six adiposity categories combining BMI with WHR/WHtR were analysed using Cox proportional hazards models. Subgroup analyses evaluated whether high central obesity (WHtR ≥ 0.6) provided additional risk stratification within BMI groups. Combined general with central obesity showed highest risk for the first condition (HR 1.11; 95% CI 1.087–1.138) and multimorbidity (HR 1.13; 95% CI 1.093–1.172). However, BMI-stratified subgroup analyses, central obesity provided additional risk discrimination only among individuals in the overweight category (BMI 25–29.9 kg/m2), but not among those with BMI ≥ 30 kg/m2. Waist-based measures improved risk identification in adults with overweight BMI, supporting the potential role of combined BMI-waist approaches for earlier multimorbidity prevention.
期刊介绍:
Clinical Obesity is an international peer-reviewed journal publishing high quality translational and clinical research papers and reviews focussing on obesity and its co-morbidities. Key areas of interest are: • Patient assessment, classification, diagnosis and prognosis • Drug treatments, clinical trials and supporting research • Bariatric surgery and follow-up issues • Surgical approaches to remove body fat • Pharmacological, dietary and behavioural approaches for weight loss • Clinical physiology • Clinically relevant epidemiology • Psychological aspects of obesity • Co-morbidities • Nursing and care of patients with obesity.